|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Realized gain on marketable securities | |||||
| Share-based compensation | |||||
| Credit loss expense | |||||
| Other income - PPP loan forgiveness | |||||
| ROU asset amortization | |||||
| Change in assets and liabilities: | |||||
| Royalty receivables | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Operating lease liability | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of fixed assets | |||||
| Purchases of marketable securities | |||||
| Sales and maturities of marketable securities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from exercise of warrants | |||||
| Net proceeds from exercise of options and warrants | |||||
| Net proceeds from exercise of options | |||||
| Proceeds from issuance of common stock and warrants | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents, at beginning of year | |||||
| Cash and cash equivalents, at end of year | |||||
| Supplemental disclosure of noncash items: | |||||
| Operating lease assets obtained for operating lease liabilities | |||||
Loading...